Min Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 8
- Cancer, Hypoxia, and Metabolism 7
- MicroRNA in disease regulation 6
-
- Sarcoma Diagnosis and Treatment 11
- Ferroptosis and cancer prognosis 5
- Co-authors
- Luigi De Colibus (1 shared paper)Claudia Binda (1 shared paper)Ariel Lustig (1 shared paper)Andrea Mattevi (1 shared paper)Dale E. Edmondson (1 shared paper)Jing‐fei Dong (5 shared papers)Hong Yan Duan (11 shared papers)Chongqi Tu (13 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Cancer Management and Research (5 papers)Medicine (4 papers)International Immunopharmacology (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Min Li
134 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 500
- Molecular Biology 1.4k
- Biological Psychiatry 38
- Oncology 395
- Pulmonary and Respiratory Medicine 428
Countries citing papers authored by Min Li
This map shows the geographic impact of Min Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Li more than expected).
Fields of papers citing papers by Min Li
This network shows the impact of papers produced by Min Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Li. The network helps show where Min Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 460 | |
| 2 | 2017 | 214 | |
| 3 | 2016 | 88 | |
| 4 | 2014 | 84 | |
| 5 | 2018 | 68 | |
| 6 | 2014 | 66 | |
| 7 | 2017 | 63 | |
| 8 | 2019 | 63 | |
| 9 | 2016 | 61 | |
| 10 | 2017 | 61 | |
| 11 | 2015 | 58 | |
| 12 | 2020 | 57 | |
| 13 | 2017 | 51 | |
| 14 | Silencing of VEGF inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT signaling pathway. | 2016 | 50 |
| 15 | 2018 | 50 | |
| 16 | 2009 | 49 | |
| 17 | 2017 | 46 | |
| 18 | 2005 | 44 | |
| 19 | 2019 | 44 | |
| 20 | 2013 | 42 |
About Min Li
Min Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Rheumatology and Oncology, having authored 143 papers that have together received 3.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers), Bone Tumor Diagnosis and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (5 papers) and Cardiac tumors and thrombi (4 papers). The work is most often cited by research in Cancer Research (500 citations), Molecular Biology (1.4k citations), Biological Psychiatry (38 citations), Oncology (395 citations) and Pulmonary and Respiratory Medicine (428 citations). Min Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Luigi De Colibus, Claudia Binda, Ariel Lustig, Andrea Mattevi, Dale E. Edmondson, Jing‐fei Dong, Hong Yan Duan, Chongqi Tu, Zilong Zhao and Wenli Zhang. Their work appears in journals such as Frontiers in Oncology, Cancer Management and Research, Medicine, International Immunopharmacology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.